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Response to comments on “The role of appetite-related hormones, adaptive thermogenesis, 
perceived hunger and stress in long-term weight-loss maintenance: a mixed-methods study”  
 
George Thom, Stephan U Dombrowski, Naomi Brosnahan, Yasmin Y Algindan, M. Rosario 
Lopez-Gonzalez, Giles Roditi, Michael EJ Lean, Dalia Malkova 
 
To the editor: 
We thank Professor. Martins for comments on our paper (1).  She is entirely correct 
concerning the description of Figure 4c: an oversight in the original manuscript was missed 
by all co-authors and reviewers. To clarify, following diet-induced weight loss, a smaller 
reduction in plasma GLP-1 concentration was weakly correlated with greater weight regain 
at 2-years. This should be reflected in the abstract, discussion and conclusions.  
On re-examining these data, we also noticed that one data point was missed from the 
published Figure 4c, during redrafting of the manuscript and after receiving reviewers’ 
comments. We have provided a revised graph below (Figure 1) for the Results, with 
correlation r=0.5, and corrected p=0.05. This does not alter the main published messages 
from this mixed methods study which were: 1) Higher fasting GLP-1 concentrations both 
before and after diet-induced weight loss may form part of a favourable biological profile for 
long-term weight-loss maintenance; 2) Hunger/appetite was not reported by study 
participants to be difficult to manage after weight loss; and 3) Life stress and negative 
emotions were perceived as key factors interfering with self-regulation of eating behaviour 
and contributing to weight loss relapse. 
We agree with Professor Martins, that most studies of appetite and GLP-1 have primarily 
been concerned with post-prandial values and meal-induced satiety. It is a novel feature of 
our study to observe that baseline (and post weight-loss) fasting GLP-1 concentrations were 
associated with weight regain at 2-years.  These findings may be valuable and should not be 
discounted without further investigation within larger, well-controlled trials. Studies in other 
contexts have suggested that fasting gut appetite hormones may also have relevance for 
energy homeostasis. For example, studies using functional MRI have indicated that activation 
of key reward-related areas of the brain is reduced in response to images of highly palatable 
foods, which seem to occur more so in the fasted than the fed state, and likely mediated by 
satiety hormones (2). Whether this is restricted to weight loss achieved by bariatric surgery is 
unclear, but it is plausible that higher (rather than lower) concentrations of GLP-1 after diet-
induced weight loss could reduce the desire to eat during weight loss maintenance. Higher 
fasting GLP-1 concentrations have also been associated with higher resting metabolic rate 
and fat oxidation (3), so mechanisms attenuating weight regain may act on both sides of the 
energy balance equation. 
At present, we lack reliable biomarkers from which clinicians or researchers can predict 
successful weight loss and weight loss maintenance following dietary intervention (4, 5), or 
identify individuals who may require additional support, e.g. GLP-1 agonist therapy. It was 
not possible within our study to evaluate postprandial appetite hormone responses. Appetite 
trials are lengthy (typically >3 hours), undertaken in specialist research settings, and 
burdensome to participants and staff. In the original manuscript, we highlighted the work of 
the biological domain subgroup of the ADOPT project (6). This group of international 
obesity experts have suggested a template of core biological tests to be undertaken within 
research studies so that in future, pooling of data from multiple studies could be used to 
understand treatment outcomes and predict response. Although it is not the ‘gold standard’, a 
collection of fasting gut appetite hormones is considered to strike an appropriate balance 
between value and feasibility.  
We are not suggesting that fasting and postprandial GLP-1 values can be used 
interchangeably: the point that we were aiming to make in the original paper was that there is 
value in obtaining fasting measurements when it is not possible to undertake postprandial 
studies. Nonetheless, unpublished findings obtained in a study conducted within the Human 
Nutrition Unit at University of Glasgow (Rizou et al, in preparation) show significant 
correlation (r=0.8, p<0.001, Pearson correlation on logarithmically transformed data) 
between fasting and postprandial plasma GLP-1 concentrations. Study participants (n=30) 
were healthy overweight females, who conducted two identical experimental trials, separated 
by at least four months. During each trial they consumed a breakfast meal, and after four 
hours, a lunch meal. The test breakfast consisted of croissant, chocolate spread, whole milk, 
milkshake powder and sugar providing 1 g fat, 1.2 g carbohydrate, 0.25 g protein and 15 kcal 
energy per kg body mass. The test lunch consisted of white bread, mild cheddar cheese, 
butter, potato crisps, whole milk, milkshake powder and sugar providing 0.8 g fat, 1.1 g 
carbohydrate, 0.35 g protein, 13 kcal energy per kg of body mass. Postprandial blood samples 
were collected for a total duration of 7-hours at 1-hour intervals and plasma GLP-1 was 
analysed using commercially available ELISA kits (Merck, Millipore, Bioscience Division, 
UK). Because of word limits, this could not be described in detail in our original paper, but 
will be submitted for publication shortly.  
 
We thank Professor Martins for bringing to our attention the misinterpretation communicated 
in the original manuscript, and for the opportunity to add to the published paper this 
correction and further information about our study and its limitations.  
 




Figure 1. Association between weight regain (kg) between 6 and 24-months and change in 
GLP-1 from baseline to 6 months  
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